Thomas C - Search Results

1

[Advanced Prostate Cancer Consensus Conference (APCCC) 2015 in St. Gallen : Critical review of the recommendations on diagnosis and therapy of metastatic prostate cancer by a German expert panel].

Thomas C, Bögemann M, König F, Machtens S, Schostak M, Steuber T, Heidenreich A. Thomas C, et al. Urologe A. 2016 Jun;55(6):772-82. doi: 10.1007/s00120-016-0030-8. Urologe A. 2016. PMID: 26820660 Review. German.

2

[Advanced Prostate Cancer Consensus Conference 2017 : Discussion of the recommendations for diagnosis and treatment of metastatic prostate cancer by a German panel of experts].

Schostak M, König F, Bögemann M, Goebell P, Hammerer P, Machtens S, Schwentner C, Thomas C, von Amsberg G, von Rundstedt FC, Heidenreich A. Schostak M, et al. Among authors: thomas c. Urologe A. 2018 Jul;57(7):813-820. doi: 10.1007/s00120-018-0680-9. Urologe A. 2018. PMID: 29808368 German.

3

[Pelvic lymphadenectomy and radical prostatectomy. Recommendations of the German S3 guideline].

Grimm MO, Thomas C, Fröhner M, Wiegel T, Heidenreich A, Thüroff JW, Wirth M. Grimm MO, et al. Among authors: thomas c. Urologe A. 2010 Feb;49(2):206-10. doi: 10.1007/s00120-010-2237-4. Urologe A. 2010. PMID: 20180060 German.

4

[Metastasized prostate cancer. Position paper on the use of chemotherapy].

Ohlmann CH, Duensing S, Eichenauer R, König F, Machtens S, Schostak M, Thomas C, Albers P. Ohlmann CH, et al. Among authors: thomas c. Urologe A. 2015 Jul;54(7):998-1001. doi: 10.1007/s00120-015-3841-0. Urologe A. 2015. PMID: 25962469 German.

5

[Metastatic castration-resistant prostate cancer : Use of cabazitaxel taking into consideration current data].

Gschwend JE, Albers P, Bögemann M, Goebell P, Heidenreich A, Klier J, König F, Machtens S, Pantel K, Thomas C. Gschwend JE, et al. Among authors: thomas c. Urologe A. 2018 Jan;57(1):34-39. doi: 10.1007/s00120-017-0533-y. Urologe A. 2018. PMID: 29071398 German.

6

[Combination therapy for metastatic hormone-sensitive prostate cancer: What? When? For whom?].

Thomas C, Ohlmann CH. Thomas C, et al. Urologe A. 2020 Jun;59(6):665-672. doi: 10.1007/s00120-020-01189-7. Urologe A. 2020. PMID: 32274544 Review. German.

7

[Treatment of primary oligometastatic prostate cancer].

Scharl S, Hadaschik B, Wiegel T, Thomas C. Scharl S, et al. Among authors: thomas c. Urologe A. 2021 Dec;60(12):1527-1533. doi: 10.1007/s00120-021-01643-0. Epub 2021 Nov 26. Urologe A. 2021. PMID: 34825936 Review. German.

8

[Therapy choices of German urologists and radio-oncologists if personally diagnosed with localized prostate cancer].

Gillitzer R, Hampel C, Thomas C, Schmidt F, Melchior SW, Pahernik S, Schmidberger H, Thüroff JW. Gillitzer R, et al. Among authors: thomas c. Urologe A. 2009 Apr;48(4):399-407. doi: 10.1007/s00120-008-1928-6. Urologe A. 2009. PMID: 19352607 German.

9

[Patients with metastatic hormone-refractory prostate cancer. Second-line chemotherapy with mitoxantrone plus prednisone].

Thomas C, Hadaschik BA, Thüroff JW, Wiesner C. Thomas C, et al. Urologe A. 2009 Sep;48(9):1070-4. doi: 10.1007/s00120-009-2006-4. Urologe A. 2009. PMID: 19513599 Clinical Trial. German.

10

[Apalutamide for metastatic, castration-sensitive prostate cancer].

Thomas C. Thomas C. Urologe A. 2019 Dec;58(12):1496-1497. doi: 10.1007/s00120-019-01071-1. Urologe A. 2019. PMID: 31712857 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,660 results

Search Page

Filters